These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 478062)

  • 1. Percutaneous absorption of chlorquinaldol (Sterosan).
    Degen PH; Moppert J; Schmid K; Weirich EG
    Dermatologica; 1979; 159(3):239-44. PubMed ID: 478062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Percutaneous absorption of clioquinol (Vioform).
    Degen PH; Moppert J; Schmid K; Weirich EG
    Dermatologica; 1979; 159(4):295-301. PubMed ID: 157893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Experiences with sterosan-hydrocortisone ointment and the experimental preparation R 1651/3 (sterosanhydrocortisone cream) in dermatological practice].
    FRITSCH J
    Dtsch Med J; 1960 Feb; 11():69-71. PubMed ID: 13825272
    [No Abstract]   [Full Text] [Related]  

  • 4. Assessment of topical corticosteroid activity using the vasoconstriction assay in healthy volunteers.
    Görne RC; Greif C; Metzner U; Wigger-Alberti W; Elsner P
    Skin Pharmacol Physiol; 2007; 20(3):133-40. PubMed ID: 17191036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies on the metabolism and disposition of the new retinoid 4-[(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthyl)carbamoyl]benzoic acid. 5th communication: factors affecting percutaneous absorption in rats.
    Mizojiri K; Okabe H; Sugeno K; Esumi Y; Takaichi M; Okamura Y; Kashiwazaki K; Takahashi N
    Arzneimittelforschung; 1997 Mar; 47(3):270-5. PubMed ID: 9105545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Topical treatment of various dermatoses with 0.1% difluocartolone valerate with 1% chlorquinaldol (cream)].
    Ogarrio González SR
    Prensa Med Mex; 1977; 42(1-2):103-5. PubMed ID: 896646
    [No Abstract]   [Full Text] [Related]  

  • 7. Percutaneous absorption of salicylic acid in man after topical administration of three different formulations.
    Schwarb FP; Gabard B; Rufli T; Surber C
    Dermatology; 1999; 198(1):44-51. PubMed ID: 10026401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Sterosan-hydrocortisone ointment in the therapy of several skin diseases].
    MANFERTO G
    Minerva Dermatol; 1959 Dec; 34():748-50. PubMed ID: 14420594
    [No Abstract]   [Full Text] [Related]  

  • 9. [Percutaneous absorption of triamcinolone 16 alpha, 17 alpha cyclopentylene-dioxy-21-acetate (author's transl)].
    Meynadier J; Guilhou JJ; Peyron JL
    Dermatologica; 1981; 162(5):336-41. PubMed ID: 7250468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Use of difluocortolone valerate chlorquinaldol cream in dermatoses with aggregate complications].
    Carvajal Rosado M
    Prensa Med Mex; 1977; 42(1-2):100-2. PubMed ID: 331299
    [No Abstract]   [Full Text] [Related]  

  • 11. Chlorquinaldol (sterosan)-hydrocortisone in skin disorders of infants.
    FORTIER D; SIMARD R
    Can Med Assoc J; 1959 Dec; 81(12):996-9. PubMed ID: 13824058
    [No Abstract]   [Full Text] [Related]  

  • 12. Percutaneous absorption of amorolfine following a single topical application of an amorolfine cream formulation.
    Roncari G; Ponelle C; Zumbrunnen R; Guenzi A; Dingemanse J; Jonkman JH
    Clin Exp Dermatol; 1992 Sep; 17 Suppl 1():33-6. PubMed ID: 1458662
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of In Vitro and In Vivo Percutaneous Absorption Across Human Skin Using BAY1003803 Formulated as Ointment and Cream.
    Günther C; Kowal K; Schmidt T; Jambrecina A; Toner F; Nave R
    Clin Pharmacol Drug Dev; 2020 Jul; 9(5):582-592. PubMed ID: 31647607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Sterosan-hydrocortisone ointment; clinical studies].
    HEILESEN B
    Ugeskr Laeger; 1959 Sep; 121():1357-60. PubMed ID: 14400636
    [No Abstract]   [Full Text] [Related]  

  • 15. Chlorquinaldol ("Steroxin") with hydrocortisone in the therapy of common dermatoses.
    Rosanove R
    Med J Aust; 1966 Jan; 1(2):54-5. PubMed ID: 5902021
    [No Abstract]   [Full Text] [Related]  

  • 16. The percutaneous absorption of topically applied tretinoin and its effect on endogenous concentrations of tretinoin and its metabolites after single doses or long-term use.
    Latriano L; Tzimas G; Wong F; Wills RJ
    J Am Acad Dermatol; 1997 Mar; 36(3 Pt 2):S37-46. PubMed ID: 9091507
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The combination of 5,7-dichloro-8-hydroxyquinaldine (sterosan) with hydrocortisone in superficial dermatological therapy].
    BONANNI MP
    Minerva Dermatol; 1959 Sep; 34():639-44. PubMed ID: 13802428
    [No Abstract]   [Full Text] [Related]  

  • 18. [Locacorten-vioform and sterosan-hydrocortisone--a double-blind study of their effects on infected eczemas].
    Björnberg A; Hellgren L
    Dermatol Wochenschr; 1966 Nov; 152(46):1249-51. PubMed ID: 4224580
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect on plasma cortisol level and urinary cortisol excretion, in healthy volunteers, after application of three different topical steroid ointments under occlusion.
    Scott M; Malmsten LA; Thelin I
    Acta Derm Venereol; 1981; 61(6):543-6. PubMed ID: 6177167
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The guinea-pig: an animal model for human skin absorption of hydrocortisone, testosterone and benzoic acid?
    Andersen KE; Maibach HI; Anjo MD
    Br J Dermatol; 1980 Apr; 102(4):447-53. PubMed ID: 7387887
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.